User:Inorton/Slicer4:DTMRI Thoughts
From NAMIC Wiki
Audiences
- Clinical/research end users: need simple, efficient, relatively intuitive workflow to generate tractography and perform selection and statistics operations.
- Pipeline users: the underlying implementations need to be abstracted sufficiently to allow creation of pipeline tools for large-study purposes.
- Clinical developers: integrate DTI functionality for domain-specific purposes (neurosurgery, neurology, etc.)
- DTI Researchers:
- Could use Slicer+ipython+numpy+... instead of matlab and custom code. Advantages: data-reading and visualization boilerplate code already exists. Disadvantages: learning curve; the python suite is less integrated than matlab, but it's getting better. Stability: matlab rarely crashes.
- Implementation of new algorithms in Slicer opens up larger userbase.
Slicer advantages
There are several excellent DTI-centric applications (see big list of DTI software: User:inorton/DTI_Software). What advantages does Slicer have for DTI work?
- More user-friendly data loading: TrackVis requires command line preprocessing; MedInria and TrackVis require manual gradient entry; DTI studio is limited to ROI exploration only (as far as I know)
- Many segmentation options already available - no external tool (TrackVis, DTI Studio) or separate interface (MedInria) required.
- Already integrated with intra-operative systems via OpenIGTLink functionality
- Open-source license (TrackVis closed, MedInria is non-commercial, DTI Studio closed)
- DicomToNRRDConverter test suite: testing process in development for images from many different scanner types.
Slicer disadvantages
(this is referring to Slicer3: these areas need improvement in Slicer 4)
- Current fiber data model is inefficient for large (tens of thousands) of fiber tracts.
- Missing good ROI selection, clustering, and editing capability for pre-computed fibersets.
- Subset selection and separation is inefficient.
- Labelmap seeding is not multi-threaded so whole-brain tractography takes forever.